PHARMATRENTE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMATRENTE
Largest movements
- Tangible fixed assets +€85,422
up €85,422 (+29.4%), from €290,399 to €375,821
of which Other tangible fixed assets: +€73,602
- Cash +€36,984
up €36,984 (+41.4%), from €89,284 to €126,267
mainly Trade debts (+€152,850) and Net result for the year (+€98,595)
- Stocks and contracts +€14,578
up €14,578 (+10.4%), from €140,066 to €154,644
- Trade debts +€152,850
up €152,850 (+53.6%), from €285,237 to €438,087
- Other debts +€55,004
up €55,004 (+72.4%), from €76,000 to €131,004
- Debts after one year -€29,984
down €29,984 (-16.6%), from €180,868 to €150,884
- Current portion of long-term debt -€25,557
down €25,557 (-25.2%), from €101,481 to €75,924
- Staff costs -€22,556
down €22,556 (-9.7%), from €231,888 to €209,332
- Gross operating margin +€14,758
up €14,758 (+3.9%), from €376,915 to €391,673
- Depreciation +€6,303
up €6,303 (+32.2%), from €19,589 to €25,891
- Taxes +€5,798
up €5,798 (+19.5%), from €29,807 to €35,606
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €781,678 | €924,033 | +€142,355 | +18.2% |
| Fixed assets | 21/28 | €291,935 | €377,357 | +€85,422 | +29.3% |
| Tangible fixed assets | 22/27 | €290,399 | €375,821 | +€85,422 | +29.4% |
| Land and buildings | 22 | €228,364 | €217,246 | -€11,118 | -4.9% |
| Furniture and vehicles | 24 | €12,119 | €35,057 | +€22,937 | +189% |
| Other tangible fixed assets | 26 | €49,916 | €123,518 | +€73,602 | +147% |
| Financial fixed assets | 28 | €1,536 | €1,536 | = | 0.0% |
| Current assets | 29/58 | €489,743 | €546,677 | +€56,933 | +11.6% |
| Stocks and contracts in progress | 3 | €140,066 | €154,644 | +€14,578 | +10.4% |
| Stocks | 30/36 | €140,066 | €154,644 | +€14,578 | +10.4% |
| Amounts receivable within one year | 40/41 | €255,625 | €260,878 | +€5,253 | +2.1% |
| Trade receivables | 40 | €162,474 | €252,950 | +€90,476 | +55.7% |
| Other amounts receivable | 41 | €93,151 | €7,928 | -€85,223 | -91.5% |
| Cash at bank and in hand | 54/58 | €89,284 | €126,267 | +€36,984 | +41.4% |
| Deferred charges and accrued income | 490/1 | €4,768 | €4,887 | +€119 | +2.5% |
| Total equity and liabilities | 10/49 | €781,678 | €924,033 | +€142,355 | +18.2% |
| Equity | 10/15 | €93,953 | €92,148 | -€1,805 | -1.9% |
| Contributions | 10/11 | €57,000 | €57,000 | = | 0.0% |
| Revaluation surpluses | 12 | €528 | €528 | = | 0.0% |
| Reserves | 13 | €34,832 | €32,982 | -€1,850 | -5.3% |
| Tax-exempt reserves | 132 | €32,074 | €30,225 | -€1,850 | -5.8% |
| Distributable reserves | 133 | €2,758 | €2,758 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,593 | €1,638 | +€45 | +2.8% |
| Provisions and deferred taxes | 16 | €16,516 | €15,563 | -€952 | -5.8% |
| Deferred taxes | 168 | €16,516 | €15,563 | -€952 | -5.8% |
| Amounts payable | 17/49 | €671,210 | €816,322 | +€145,112 | +21.6% |
| Amounts payable after more than one year | 17 | €180,868 | €150,884 | -€29,984 | -16.6% |
| Financial debts | 170/4 | €180,868 | €150,884 | -€29,984 | -16.6% |
| Amounts payable within one year | 42/48 | €490,342 | €664,938 | +€174,596 | +35.6% |
| Current portion of amounts payable after more than one year | 42 | €101,481 | €75,924 | -€25,557 | -25.2% |
| Trade debts | 44 | €285,237 | €438,087 | +€152,850 | +53.6% |
| Suppliers | 440/4 | €285,237 | €438,087 | +€152,850 | +53.6% |
| Taxes, remuneration and social security | 45 | €27,625 | €19,923 | -€7,701 | -27.9% |
| Taxes | 450/3 | €512 | - | -€512 | |
| Remuneration and social security | 454/9 | €27,113 | €19,923 | -€7,189 | -26.5% |
| Other amounts payable | 47/48 | €76,000 | €131,004 | +€55,004 | +72.4% |
| Accrued charges and deferred income | 492/3 | - | €500 | +€500 | |
| Remuneration, social security and pensions | 62 | €231,888 | €209,332 | -€22,556 | -9.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,589 | €25,891 | +€6,303 | +32.2% |
| Other operating charges | 640/8 | €876 | €980 | +€103 | +11.8% |
| Gross operating margin | 9900 | €376,915 | €391,673 | +€14,758 | +3.9% |
| Operating profit (loss) | 9901 | €124,563 | €155,471 | +€30,908 | +24.8% |
| Financial income | 75/76B | €152 | €220 | +€67 | +44.2% |
| Recurring financial income | 75 | €152 | €220 | +€67 | +44.2% |
| Financial charges | 65/66B | €20,832 | €22,442 | +€1,610 | +7.7% |
| Recurring financial charges | 65 | €20,832 | €22,442 | +€1,610 | +7.7% |
| Profit (loss) for the period before taxes | 9903 | €103,883 | €133,248 | +€29,365 | +28.3% |
| Transfer from deferred taxes | 780 | €952 | €952 | = | 0.0% |
| Income taxes | 67/77 | €29,807 | €35,606 | +€5,798 | +19.5% |
| Profit (loss) for the period | 9904 | €75,028 | €98,595 | +€23,567 | +31.4% |
| Transfer from tax-exempt reserves | 789 | €1,850 | €1,850 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €76,878 | €100,445 | +€23,567 | +30.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.